Paul Bolaji Invites You to Nigerian Stroke Leaders’ Summit 2025
Paul Bolaji, Education Lead (Stroke Services) at Dorset County Hospital NHS Foundation Trust, shared on LinkedIn:
”Nigerian Stroke Leaders’ Summit 2025
Calling Stroke Leaders Across Nigeria!
Are you a changemaker in stroke care?
From prehospital response to acute care and rehabilitation your voice matters!
It’s time for us to come together and transform stroke care in Nigeria.
Join fellow leaders, Neurologists, Clinicians, Surgeons involved in Stroke Care, Stroke therapists, Stroke Nurses, Stroke advocates, and innovators as we deliberate and build solutions to improve stroke outcomes nationwide
Dates: 10–11 December 2025
Time: 1:00 PM – 5:00 PM (WAT)
Venue: Virtual (Zoom)
Pls do message me personally if you are a stroke leader in Nigeria to get access to the link
Hosts and Organisers
• Nigerian Stroke Organization (NSO)
• Nigerian Society of Neurological Sciences (NSNS)
• African Stroke Organization (ASO)
Do you want to improve stroke care in Nigeria?
Are you ready to be part of the change?
Then this is your moment.”
Stay updated with Hemostasis Today.
-
Mar 11, 2026, 18:27Cesar Garrido and Lackram Bodoe Are Advancing WFH Partnerships in Trinidad and Tobago
-
Mar 11, 2026, 18:14Aloke Finn: Silent Plaque Rupture and Healing in Coronary Artery Disease
-
Mar 11, 2026, 17:23Mattia Galli: A Privilege to Collaborate on Such a Complex Topic as Cardio-Rheumatology
-
Mar 11, 2026, 17:12Shubham Misra: Proteomic Biomarkers for Acute Stroke Subtype Classification
-
Mar 11, 2026, 16:55Melanie Daniel: Modeling High-Purity von Willebrand Factor for Individualized Dosing in Surgery
-
Mar 11, 2026, 15:46Bleeding and Thrombosis Outcomes in Older Patients With Myelodysplastic Syndromes – JTH
-
Mar 11, 2026, 15:37Sonia Muliyil: The Greatest Benefit is The Wellbeing and Sustenance of Half The World’s Population
-
Mar 11, 2026, 15:34Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation
-
Mar 11, 2026, 15:34Sheharyar Raza: When More Testing Isn’t Always Better in Healthy Donor Screening